Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Review Article Volume 6 Issue 5

Recent Trends in Nano-Drug Delivery Systems for Breast, Prostate, Brain, and Other Cancers

Kinnera K1, Kevin Sneed2 and Yashwant V Pathak2*

1Judy Genshaft Honors College, University of South Florida, USA
2Taneja College of Pharmacy, University of South Florida, Tampa, USA

*Corresponding Author: Yashwant V Pathak, Taneja College of Pharmacy, University of South Florida, Tampa, USA, ypathak1@usf.edu.

Received: January 27, 2022; Published: April 20, 2022

Abstract

Nano delivery system as well as Nano medicine is new initiative; however, it develops pharmaceutical science increasingly. Nanotechnology has several benefits to treat many chronic health issues, especially, cancer by target-oriented delivery of appropriate medicines. This assignment was about reviewing the existing literature on the Nano medicine and Nano drug delivery system, in context of different toes of cancer.           It has discussed various nano particles that are considered for cancer treatment such as polymers, liposome, dendrimers, protein nano particles, and cellulose. It has provided information about both organic and inorganic nano particles.

The findings have shown that in case of nano-drug delivery of cancer, lipid, dendrimers, polymers, and liposome highlighted promising results. This review presents update summary of recent trends within NDDS and nanomedicine by comprehensive scrutiny of application and delivery of nanoparticles by improving efficacy of old and novel drugs. Lastly, it has provided short information on future of NDDS and nanomedicine based on the collected information. That information indicates that since nanotechnology is increasing day-by-day, it has an emerging future. Additionally, researchers have the chance to develop effective treatment solution with help of nanomedicine. This is a literature review which covers various aspects of recent trends in nano drug delivery systems with focus on selected cancers.

Keywords: Nano Drug Delivery Systems; Breast Cancer; Prostate Cancer; Cancer Treatment; Nanomaterials in Cancer Therapy

References

  1. Abo-Elseoud W S., et al. “Chitosan nanoparticles/cellulose nanocrystals nanocomposites as a carrier system for the controlled release of repaglinide”. International Journal of Biological Macromolecules 111 (2018): 604-613.
  2. Alonso J., et al. “Superparamagnetic nanoparticles encapsulated in lipid vesicles for advanced magnetic hyperthermia and biodetection”. Journal of Applied Physics8 (2016): 083904.
  3. Alqaraghuli H G J., et al. “A review on targeting nanoparticles for breast cancer”. Current Pharmaceutical Biotechnology13 (2019): 1087-1107.
  4. Amararathna M., et al. “Pulmonary nano-drug delivery systems for lung cancer: current knowledge and prospects”. Journal of Lung Health and Diseases2 (2019).
  5. Bazak R., et al. “Passive targeting of nanoparticles to cancer: A comprehensive review of the literature”. Molecular and Clinical Oncology6 (2014): 904-908.
  6. Chen G., et al. “Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy”. Chemical Reviews5 (2016): 2826-2885.
  7. Costa J R., et al. “Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin”. European Journal of Clinical Microbiology and Infectious Diseases6 (2015): 1255-1262.
  8. Cui W., et al. “Discovering anti-cancer drugs via computational methods”. Frontiers in Pharmacology 11 (2020): 733.
  9. Dadwal A., et al. “Nanoparticles as carriers for drug delivery in cancer”. Artificial Cells, Nanomedicine, and Biotechnology 46 (2018): 295-305.
  10. Dang Y and Guan J. “Nanoparticle-based drug delivery systems for cancer therapy”. Smart Materials in Medicine 1 (2020): 10-19.
  11. Fang X., et al. “Advances in anti-breast cancer drugs and the application of nano-drug delivery systems in breast cancer therapy”. Journal of Drug Delivery Science and Technology 57 (2020): 101662.
  12. Gao N and Mei L. “Black phosphorus‐based nano‐drug delivery systems for cancer treatment: Opportunities and challenges”. Asian Journal of Pharmaceutical Sciences1 (2021): 1.
  13. Guo J., et al. “Emerging nano drug delivery systems targeting cancer-associated fibroblasts for improved antitumor effect and tumor drug penetration”. Molecular Pharmaceutics4 (2020): 1028-1048.
  14. Hema S., et al. “Nanoformulations for targeted drug delivery to prostate cancer: an overview”. Journal of Nanoscience and Nanotechnology8 (2018): 5171-5191.
  15. Huang J., et al. “Novel in situ forming hydrogel based on xanthan and chitosan re-gelifying in liquids for local drug delivery”. Carbohydrate Polymers 186 (2018): 54-63.
  16. Hussain S. “Nanomedicine for treatment of lung cancer”. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management (2016): 137-147.
  17. Jain P., et al. “Clinical therapies and nano drug delivery systems for urinary bladder cancer”. Pharmacology and Therapeutics (2021): 107871.
  18. Jin K T., et al. “Recent trends in nanocarrier-based targeted chemotherapy: selective delivery of anticancer drugs for effective lung, colon, cervical, and breast cancer treatment”. Journal of Nanomaterials (2020).
  19. Junyaprasert V B., et al. “Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs”. Asian Journal of Pharmaceutical Sciences1 (2015): 13-23.
  20. Kudr J., et al. “Magnetic nanoparticles: From design and synthesis to real world applications”. Nanomaterials9 (2017): 243.
  21. Lalan M., et al. “Skin cancer therapeutics: nano-drug delivery vectors—present and beyond”. Future Journal of Pharmaceutical Sciences 1 (2021): 1-25.
  22. Le QV., et al. “Nano delivery systems and cancer immunotherapy”. Journal of Pharmaceutical Investigation5 (2018): 527-539.
  23. Li J., et al. “Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review”. International Journal of Nanomedicine 15 (2020): 2563.
  24. Li Z., et al. “Cancer drug delivery in the nano era: An overview and perspectives”. Oncology Reports2 (2017): 611-624.
  25. Liyanage P Y., et al. “Nanoparticle-mediated targeted drug delivery for breast cancer treatment”. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 2 (2019): 419-433.
  26. Lohcharoenkal W., et al. “Protein nanoparticles as drug delivery carriers for cancer therapy”. BioMed Research International (2014).
  27. Madamsetty VS., et al. “Recent trends of the bio-inspired nanoparticles in cancer theranostics”. Frontiers in Pharmacology 10 (2019): 1264.
  28. Mangal S., et al. “Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities”. Acta Pharmacologica Sinica6 (2017): 782-797.
  29. Mattos BD., et al. “Biogenic silica nanoparticles loaded with neem bark extract as green, slow-release biocide”. Journal of Cleaner Production 142 (2017): 4206-4213.
  30. McNamara K and Tofail S A. “Nanoparticles in biomedical applications”. Advances in Physics: X1 (2017): 54-88.
  31. Milewska S., et al. “Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment”. International Journal of Nanomedicine 16 (2021): 6593.
  32. Naeem M., et al. “Advances in colon-targeted nano-drug delivery systems: challenges and solutions”. Archives of Pharmacal Research1 (2020): 153-169.
  33. Navya P N., et al. “Current trends and challenges in cancer management and therapy using designer nanomaterials”. Nano Convergence1 (2019): 1-30.
  34. Patra J K., et al. “Nano based drug delivery systems: recent developments and future prospects”. Journal of Nanobiotechnology1 (2018): 1-33.
  35. Pistone S., et al. “Formulation of polysaccharide-based nanoparticles for local administration into the oral cavity”. European Journal of Pharmaceutical Sciences 96 (2017): 381-389.
  36. R Rama A., et al. “Last advances in nanocarriers-based drug delivery systems for colorectal cancer”. Current Drug Delivery6 (2016): 830-838.
  37. Rana V and Sharma R. “Recent advances in development of nano drug delivery”. Applications of Targeted Nano Drugs and Delivery Systems (2019): 93-131.
  38. Román J V., et al. “Preparation and preliminary evaluation of alginate crosslinked microcapsules as potential drug delivery system (DDS) for human lung cancer therapy”. Biomedical Physics and Engineering Express3 (2016): 035015.
  39. Sahu A., et al. “Recent progress in the design of hypoxia‐specific nano drug delivery systems for cancer therapy”. Advanced Therapeutics4 (2018): 1800026.
  40. Salapa J., et al. “Nano drug delivery systems in upper gastrointestinal cancer therapy”. Nano Convergence 1 (2020): 1-17.
  41. Senapati S., et al. “Controlled drug delivery vehicles for cancer treatment and their performance”. Signal Transduction and Targeted Therapy 1 (2018): 1-19.
  42. Shao J., et al. “Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid”. Asian Journal of Pharmaceutical Sciences (2020).
  43. Shi Y., et al. “Multifunctional biocompatible graphene oxide quantum dots decorated magnetic nanoplatform for efficient capture and two-photon imaging of rare tumor cells”. ACS Applied Materials and Interfaces20 (2015): 10935-10943.
  44. Subramanian A P., et al. “Recent trends in nano-based drug delivery systems for efficient delivery of phytochemicals in chemotherapy”. RSC Advances54 (2016): 48294-48314.
  45. Sun B., et al. “Applications of cellulose-based materials in sustained drug delivery systems”. Current Medicinal Chemistry14 (2019): 2485-2501.
  46. Sutradhar KB and Amin M. “Nanotechnology in cancer drug delivery and selective targeting”. International Scholarly Research Notices (2014).
  47. Wakaskar RR. “Polymeric micelles for drug delivery”. International Journal of Drug Development Research 9 (2017): 1-2.
  48. Xu J., et al. “Cancer nanotechnology: recent trends and developments in strategies for targeting cancer cells to improve cancer imaging and treatment”. Current Drug Metabolism4 (2017): 266-279.
  49. Yao Y., et al. “Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance”. Frontiers in Molecular Biosciences (2020): 7.
  50. Ying M., et al. “Recent advances and strategies in tumor vasculature targeted nano-drug delivery systems”. Current Pharmaceutical Design22 (2015): 3066-3075.
  51. Zhang X., et al. “Layer-by-Layer assembled nano-drug delivery systems for cancer treatment”. Drug Delivery1 (2021): 655-669.
  52. Zou T., et al. “A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment”. European Journal of Pharmaceutics and Biopharmaceutics 166 (2021): 30-43.

Citation

Citation: Kinnera K., et al. “The Neonates' Body Length and Body Weight in Two Different Periods of Time”.Acta Scientific Medical Sciences 6.5 (2022): 144-155.

Copyright

Copyright: © 2022 Kinnera K., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US